Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
-2.19%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$58.7B
AUM Growth
-$10.7B
Cap. Flow
-$8.61B
Cap. Flow %
-14.68%
Top 10 Hldgs %
11.75%
Holding
4,329
New
465
Increased
1,330
Reduced
1,796
Closed
718

Sector Composition

1 Technology 19.27%
2 Healthcare 18.45%
3 Consumer Discretionary 12.35%
4 Consumer Staples 10.15%
5 Industrials 9.9%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
VIS icon
2451
Vanguard Industrials ETF
VIS
$6.17B
$799K ﹤0.01%
4,100
-600
-13% -$117K
VOE icon
2452
Vanguard Mid-Cap Value ETF
VOE
$18.9B
$799K ﹤0.01%
6,100
+2,100
+53% +$275K
ATYR
2453
aTyr Pharma
ATYR
$99.9M
$799K ﹤0.01%
505,993
-20,362
-4% -$32.2K
TECX
2454
Tectonic Therapeutic, Inc. Common Stock
TECX
$300M
$798K ﹤0.01%
43,206
-3,675
-8% -$67.9K
NMR icon
2455
Nomura Holdings
NMR
$22B
$797K ﹤0.01%
198,290
-732,900
-79% -$2.95M
RCKY icon
2456
Rocky Brands
RCKY
$221M
$796K ﹤0.01%
54,135
-7,600
-12% -$112K
FTRE icon
2457
Fortrea Holdings
FTRE
$913M
$792K ﹤0.01%
+27,700
New +$792K
OGN icon
2458
Organon & Co
OGN
$2.72B
$792K ﹤0.01%
45,637
-279,863
-86% -$4.86M
TLH icon
2459
iShares 10-20 Year Treasury Bond ETF
TLH
$11.6B
$788K ﹤0.01%
+8,000
New +$788K
CTLP icon
2460
Cantaloupe
CTLP
$795M
$786K ﹤0.01%
125,800
-4,800
-4% -$30K
HHH icon
2461
Howard Hughes
HHH
$4.88B
$786K ﹤0.01%
11,119
-24,967
-69% -$1.76M
MBI icon
2462
MBIA
MBI
$361M
$783K ﹤0.01%
108,559
+54,585
+101% +$394K
FXE icon
2463
Invesco CurrencyShares Euro Currency Trust
FXE
$535M
$782K ﹤0.01%
8,000
+100
+1% +$9.78K
CSBR icon
2464
Champions Oncology
CSBR
$96.1M
$781K ﹤0.01%
125,791
+900
+0.7% +$5.59K
SCHM icon
2465
Schwab US Mid-Cap ETF
SCHM
$12.2B
$778K ﹤0.01%
34,500
+16,500
+92% +$372K
EELV icon
2466
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$408M
$772K ﹤0.01%
34,300
-21,500
-39% -$484K
EPP icon
2467
iShares MSCI Pacific ex Japan ETF
EPP
$1.84B
$772K ﹤0.01%
19,400
-24,100
-55% -$959K
ZYNE
2468
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$772K ﹤0.01%
605,700
-84,013
-12% -$107K
BNL icon
2469
Broadstone Net Lease
BNL
$3.5B
$771K ﹤0.01%
53,900
-9,000
-14% -$129K
RNAC icon
2470
Cartesian Therapeutics
RNAC
$250M
$770K ﹤0.01%
24,200
-9,217
-28% -$293K
HIPO icon
2471
Hippo Holdings
HIPO
$931M
$770K ﹤0.01%
96,604
+15,300
+19% +$122K
AOM icon
2472
iShares Core Moderate Allocation ETF
AOM
$1.6B
$767K ﹤0.01%
19,700
-14,800
-43% -$576K
HYFM icon
2473
Hydrofarm Holdings
HYFM
$14.6M
$767K ﹤0.01%
62,890
+1,110
+2% +$13.5K
SPRU icon
2474
Spruce Power Holding Corp
SPRU
$31.4M
$766K ﹤0.01%
140,750
+3,525
+3% +$19.2K
HEFA icon
2475
iShares Currency Hedged MSCI EAFE ETF
HEFA
$6.67B
$765K ﹤0.01%
25,400
-25,300
-50% -$762K